Raymond DuBois (academic)

DuBois attended Texas A&M University, where he received a bachelor's degree in biochemistry.[3][4] Later, he joined a medical school, University of Texas School of Medicine, and completed a medical degree.[3][4] He also holds a doctorate degree in biochemistry from the University of Texas.[3][4]

From 1991 to 2007, he was the director of the Vanderbilt-Ingram Cancer Center.[5][6]

Between 2007 and 2012, DuBois was the provost and executive vice president of the University of Texas MD Anderson Cancer Center.[7] He also held the Ellen Knisely Distinguished Chair in colon cancer research.[8][3]

In 2012, he joined the Biodesign Institute at Arizona State University as the executive director and served until 2016.[6][8]

In March 2016, DuBois became the dean of the College of Medicine at the Medical University of South Carolina.[3][6]

In 2019, he was elected to the National Academy of Medicine.[6]

In 2020, he was appointed as the director of Hollings Cancer Center.[6][9]

In February 2022, he was appointed as the executive chairman of the board of Mark Foundation for Cancer Research.[2]

DuBois is known for his research on the causes of cancer, its spread, and what prevents it.[6]

DuBois co-invented a method for identifying and targeting cellular genes required for viral development, as well as cellular genes that act as tumour suppressors in mammals.[10]

• Howard Hughes Research Associate Award (1988)[4]
• Elected member, American Society for Clinical Investigation (1997)
• Elected member, Association of American Physicians (2000)
• E.V. Newman Research Prize (2000)[4]
• AACR-Richard and Hinda Rosenthal Cancer Foundation Award (2002)[4]
• NIH MERIT Award, NIDDK (2004-2012)
• Dorothy P. Landon-AACR Cancer Research Prize (2004)[4]
• Fellow of the American Association for the Advancement of Science (2004)
• AGA Distinguished Achievement Award (2004)
• Anthony Dipple Carcinogenesis Award from Oxford University Press (2006)
• Elected, Johns Hopkins University Society of Scholars (2007)
• Catedra Gonzalo Rio Arronte Award, Mexico City, Mexico (2011)
• The Shanghai Cancer Forum Award (2013)
• Elected fellow, American Association for Cancer Research (2013)
• Elected, American Clinical and Climatological Association (2013)
• AACR Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research (2019)
• Elected, National Academy of Medicine (2019)
• Fellow of the Royal College of Physicians (2020)
• AACR Distinguished Service Award (2022)[1]

• DuBios, Raymond N. (2003). Cox-2: A New Target for Cancer Prevention and Treatment